Key Metrics
CiteScore 

5.8
Impact Factor 

5 - 10
SJR 

Q3Immunology

SNIP 

1.63
Recommended pre-submission checks
Powered by 

Topics Covered on World Allergy Organization Journal
World Allergy Organization Journal Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
DOAJ
SJR
| Overview | |
| Publisher | ELSEVIER |
| Language | English |
| Frequency | Monthly |
| Article Processing Charges | USD 2540 |
| Publication Time | 9 |
| Editorial Review Process | Double anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | World Allergy Organization |
| Frequency | Monthly |
| Publication Start Year | 2008 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC-ND |
| OA statement | Visit website |
View less
Planning to publish in World Allergy Organization Journal ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in World Allergy Organization Journal
Short-term high-dose budesonide nasal spray for postoperative uncontrolled chronic rhinosinusitis: A randomized controlled trial
- 1 May 2026
- World Allergy Organization Journal
Efficacy predictions for omalizumab treatment based on basophil CD203c expression in patients with allergic rhinitis by basophil activation test -- a real-life, pilot study.
- 1 May 2026
- The World Allergy Organization journal
Overview of allergic disease: Pathogenesis of allergic inflammation - WAO White Book on Allergy 2026 - 2.1.
- 1 May 2026
- The World Allergy Organization journal
Real-life lessons on omalizumab and food allergy: The potential for unexplored outcomes.
- 1 May 2026
- The World Allergy Organization journal
Prevalence and risk factors of asthma, rhinoconjunctivitis and eczema in the very extreme environment of Naryn, Kyrgyzstan.
- 1 May 2026
- The World Allergy Organization journal
Corrigendum to "Retrospective analysis of the efficacy and safety of 100 mg abrocitinib in patients with moderate to severe atopic dermatitis: Real-world study" [World Allergy Organ J 16 (2) (2023) 101167
- 1 May 2026
- The World Allergy Organization journal
Short-term high-dose budesonide nasal spray for postoperative uncontrolled chronic rhinosinusitis: A randomized controlled trial
- 1 May 2026
- World Allergy Organization Journal
Efficacy predictions for omalizumab treatment based on basophil CD203c expression in patients with allergic rhinitis by basophil activation test -- a real-life, pilot study.
- 1 May 2026
- The World Allergy Organization journal
Overview of allergic disease: Pathogenesis of allergic inflammation - WAO White Book on Allergy 2026 - 2.1.
- 1 May 2026
- The World Allergy Organization journal
Real-life lessons on omalizumab and food allergy: The potential for unexplored outcomes.
- 1 May 2026
- The World Allergy Organization journal
Prevalence and risk factors of asthma, rhinoconjunctivitis and eczema in the very extreme environment of Naryn, Kyrgyzstan.
- 1 May 2026
- The World Allergy Organization journal
Corrigendum to "Retrospective analysis of the efficacy and safety of 100 mg abrocitinib in patients with moderate to severe atopic dermatitis: Real-world study" [World Allergy Organ J 16 (2) (2023) 101167
- 1 May 2026
- The World Allergy Organization journal